Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109609536B enables efficient L-carnosine production. Reduced costs and enhanced supply chain reliability for pharmaceutical intermediates.
Patent CN115896060A reveals a novel ω-transaminase mutant for silodosin synthesis, offering >99% ee and scalable biocatalysis for reliable supply chains.
Patent CN113583992A reveals a novel RsRedAm enzyme for efficient secondary amine synthesis, offering mild conditions and high selectivity for pharmaceutical intermediates.
Patent CN110382705B details a novel enzymatic route for L-Alanyl-L-Glutamine using engineered acyltransferase, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN115537405A reveals a novel ketoreductase mutant for high-purity (S)-1-(3-chlorophenyl)-1,3-propanediol production, offering significant cost reduction in API manufacturing.
Novel enzymatic route for Darunavir intermediate (3R, 3aS, 6aR)-hexahydrofuro[2,3-b]furan-3-ol offering high optical purity and industrial scalability.
Patent CN110592045B reveals high-purity enzymatic resolution for cardiovascular drug intermediates, offering scalable supply chain solutions.
Patent CN110055297B details a novel esterase for resolving (R,S)-5-caprolactone with >98% ee. Discover cost-effective biocatalytic routes for high-purity flavor intermediates.
Patent CN112899246B details novel KmAKR mutants for synthesizing chiral statin side chains with superior stability and stereoselectivity for API manufacturing.
Patent CN104099305A reveals stable CgKR1 mutants for Clopidogrel intermediates. Enhances purity and supply chain reliability for global pharmaceutical manufacturing.
Patent CN111575334B reveals a stable immobilized enzyme method for synthesizing chiral alcohols, offering significant cost reduction and supply reliability for API manufacturing.
Patent CN114277006A reveals a novel alcohol dehydrogenase for synthesizing chiral heterocyclic alcohols without organic solvents, offering significant supply chain and cost advantages.
Patent CN117051052A reveals high-purity NEB-8 synthesis via MrADH. Offers supply chain reliability and significant cost reduction in pharmaceutical intermediate manufacturing processes.
Patent CN117737149A details enzymatic synthesis for high-purity S-vitronectin. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101962661B reveals high-efficiency carbonyl reductase for statin intermediates. Offers superior yield and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN114277006B reveals a novel ADH for synthesizing chiral heterocyclic alcohols without organic solvents, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Advanced enzymatic synthesis patent analysis for high-purity Clopidogrel intermediates. Delivers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN101469318B details enzymatic synthesis achieving 100 percent e.e. purity. This report analyzes cost reduction in chiral chemical manufacturing and supply chain reliability for global buyers.
Patent CN104293848A reveals high-yield biocatalytic route for chiral intermediates. Offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Patent CN118147114A reveals beta-glucosidase mutant for phloretin. Enables cost reduction in flavonoid manufacturing and reliable supply chain scalability.